164 related articles for article (PubMed ID: 32799671)
1. The role of aldosterone inhibitors in cardiac ischemia-reperfusion injury.
Dragasevic N; Jakovljevic V; Zivkovic V; Draginic N; Andjic M; Bolevich S; Jovic S
Can J Physiol Pharmacol; 2021 Jan; 99(1):18-29. PubMed ID: 32799671
[TBL] [Abstract][Full Text] [Related]
2. The cardioprotective effects of mineralocorticoid receptor antagonists.
van den Berg TN; Rongen GA; Fröhlich GM; Deinum J; Hausenloy DJ; Riksen NP
Pharmacol Ther; 2014 Apr; 142(1):72-87. PubMed ID: 24275323
[TBL] [Abstract][Full Text] [Related]
3. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together.
Wang X; Ding Z; Yang F; Dai Y; Chen P; Theus S; Singh S; Budhiraja M; Mehta JL
Clin Sci (Lond); 2016 Aug; 130(15):1353-62. PubMed ID: 27129181
[TBL] [Abstract][Full Text] [Related]
4. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
[TBL] [Abstract][Full Text] [Related]
5. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
6. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
[TBL] [Abstract][Full Text] [Related]
8. IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury.
Moss NC; Stansfield WE; Willis MS; Tang RH; Selzman CH
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2248-53. PubMed ID: 17675566
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
Obana M; Miyamoto K; Murasawa S; Iwakura T; Hayama A; Yamashita T; Shiragaki M; Kumagai S; Miyawaki A; Takewaki K; Matsumiya G; Maeda M; Yoshiyama M; Nakayama H; Fujio Y
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H569-77. PubMed ID: 22707562
[TBL] [Abstract][Full Text] [Related]
10. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts.
Lucchinetti E; Jamnicki M; Fischer G; Zaugg M
Anesth Analg; 2008 Jan; 106(1):17-23, table of contents. PubMed ID: 18165546
[TBL] [Abstract][Full Text] [Related]
12. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
[TBL] [Abstract][Full Text] [Related]
13. Breathing nitric oxide plus hydrogen gas reduces ischemia-reperfusion injury and nitrotyrosine production in murine heart.
Shinbo T; Kokubo K; Sato Y; Hagiri S; Hataishi R; Hirose M; Kobayashi H
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H542-50. PubMed ID: 23771690
[TBL] [Abstract][Full Text] [Related]
14. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.
Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF
Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207
[TBL] [Abstract][Full Text] [Related]
15. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
[TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor antagonist BQ-123 ameliorates myocardial ischemic-reperfusion injury in rats: a hemodynamic, biochemical, histopathological and electron microscopic evidence.
Goyal SN; Bharti S; Arora S; Golechha M; Arya DS
Biomed Pharmacother; 2010 Nov; 64(9):639-46. PubMed ID: 20888175
[TBL] [Abstract][Full Text] [Related]
17. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
[TBL] [Abstract][Full Text] [Related]
18. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
[TBL] [Abstract][Full Text] [Related]
19. AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
Marques-Neto SR; Ferraz EB; Rodrigues DC; Njaine B; Rondinelli E; Campos de Carvalho AC; Nascimento JH
Cardiovasc Drugs Ther; 2014 Apr; 28(2):125-35. PubMed ID: 24258356
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
Zhang T; Li Z; Dang H; Chen R; Liaw C; Tran TA; Boatman PD; Connolly DT; Adams JW
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H299-311. PubMed ID: 22003054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
